Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Beltran Lab
Explore this Website
Home
About Us
Toggle About Us menu options
Contact Us
Job Opportunities
Videos
Affiliations
Research
Lab Team
News
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Affiliations
Research
Lab Team
News
Publications
Home
Publications
Publications
Found 54 results
Author
Title
Type
Year
Filters:
Author
is
Beltran, Himisha
[Clear All Filters]
2015
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative clinical genomics of advanced prostate cancer.
.
Cell. 161(5):1215-28.
Akamatsu S
,
Wyatt AW
,
Lin D
,
Lysakowski S
,
Zhang F
,
Kim S
,
Tse C
,
Wang K
,
Mo F
,
Haegert A
et al.
. 2015.
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.
.
Cell Rep. 12(6):922-36.
Beltran H
,
Demichelis F
. 2015.
Prostate cancer: Intrapatient heterogeneity in prostate cancer.
.
Nat Rev Urol. 12(8):430-1.
Klimstra DS
,
Beltran H
,
Lilenbaum R
,
Bergsland E
. 2015.
The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap.
.
Am Soc Clin Oncol Educ Book. :92-103.
Beltran H
,
Eng K
,
Mosquera JMiguel
,
Sigaras A
,
Romanel A
,
Rennert H
,
Kossai M
,
Pauli C
,
Faltas B
,
Fontugne J
et al.
. 2015.
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
.
JAMA Oncol. 1(4):466-74.
2014
Galletti G
,
Matov A
,
Beltran H
,
Fontugne J
,
Mosquera JMiguel
,
Cheung C
,
MacDonald TY
,
Sung M
,
O'Toole S
,
Kench JG
et al.
. 2014.
ERG induces taxane resistance in castration-resistant prostate cancer.
.
Nat Commun. 5:5548.
Beltran H
,
Kaur G
,
de España CGarcías
,
Tagawa ST
. 2014.
Exploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinib.
.
Asian J Androl. 16(4):568-9.
Lin D
,
Wyatt AW
,
Xue H
,
Wang Y
,
Dong X
,
Haegert A
,
Wu R
,
Brahmbhatt S
,
Mo F
,
Jong L
et al.
. 2014.
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.
.
Cancer Res. 74(4):1272-83.
Terry S
,
Beltran H
. 2014.
The many faces of neuroendocrine differentiation in prostate cancer progression.
.
Front Oncol. 4:60.
Chakravarty D
,
Sboner A
,
Nair SS
,
Giannopoulou E
,
Li R
,
Hennig S
,
Mosquera JMiguel
,
Pauwels J
,
Park K
,
Kossai M
et al.
. 2014.
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.
.
Nat Commun. 5:5383.
Gao D
,
Vela I
,
Sboner A
,
Iaquinta PJ
,
Karthaus WR
,
Gopalan A
,
Dowling C
,
Wanjala JN
,
Undvall EA
,
Arora VK
et al.
. 2014.
Organoid cultures derived from patients with advanced prostate cancer.
.
Cell. 159(1):176-87.
Epstein JI
,
Amin MB
,
Beltran H
,
Lotan TL
,
Mosquera J-M
,
Reuter VE
,
Robinson BD
,
Troncoso P
,
Rubin MA
. 2014.
Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.
.
Am J Surg Pathol. 38(6):756-67.
Park K
,
Chen Z
,
MacDonald TY
,
Siddiqui J
,
Ye H
,
Erbersdobler A
,
Shevchuk MM
,
Robinson BD
,
Sanda MG
,
Chinnaiyan AM
et al.
. 2014.
Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification.
.
Hum Pathol. 45(10):2136-43.
Prandi D
,
Baca SC
,
Romanel A
,
Barbieri CE
,
Mosquera J-M
,
Fontugne J
,
Beltran H
,
Sboner A
,
Garraway LA
,
Rubin MA
et al.
. 2014.
Unraveling the clonal hierarchy of somatic genomic aberrations.
.
Genome Biol. 15(8):439.
2013
Terry S
,
Maillé P
,
Baaddi H
,
Kheuang L
,
Soyeux P
,
Nicolaiew N
,
Ceraline J
,
Firlej V
,
Beltran H
,
Allory Y
et al.
. 2013.
Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.
.
Neoplasia. 15(7):761-72.
Frampton GM
,
Fichtenholtz A
,
Otto GA
,
Wang K
,
Downing SR
,
He J
,
Schnall-Levin M
,
White J
,
Sanford EM
,
An P
et al.
. 2013.
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.
.
Nat Biotechnol. 31(11):1023-31.
Beltran H
. 2013.
DNA mismatch repair in prostate cancer.
.
J Clin Oncol. 31(14):1782-4.
Lin P-C
,
Chiu Y-L
,
Banerjee S
,
Park K
,
Mosquera JMiguel
,
Giannopoulou E
,
Alves P
,
Tewari AK
,
Gerstein MB
,
Beltran H
et al.
. 2013.
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression.
.
Cancer Res. 73(3):1232-44.
Baca SC
,
Prandi D
,
Lawrence MS
,
Mosquera JMiguel
,
Romanel A
,
Drier Y
,
Park K
,
Kitabayashi N
,
MacDonald TY
,
Ghandi M
et al.
. 2013.
Punctuated evolution of prostate cancer genomes.
.
Cell. 153(3):666-77.
2012
Beltran H
,
Park K
,
Tagawa ST
,
Macdonald T
,
Nanus DM
,
Mosquera JMiguel
,
Rubin MA
. 2012.
Association of concurrent AURKA and MYCN amplification in primary prostate adenocarcinoma with the development of lethal neuroendocrine prostate cancer (NEPC).
.
J Clin Oncol. 30(5_suppl):120.
Beltran H
,
Tagawa ST
,
Park K
,
Macdonald T
,
Milowsky MI
,
Mosquera JMiguel
,
Rubin MA
,
Nanus DM
. 2012.
Challenges in recognizing treatment-related neuroendocrine prostate cancer.
.
J Clin Oncol. 30(36):e386-9.
Lapuk AV
,
Wu C
,
Wyatt AW
,
McPherson A
,
McConeghy BJ
,
Brahmbhatt S
,
Mo F
,
Zoubeidi A
,
Anderson S
,
Bell RH
et al.
. 2012.
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.
.
J Pathol. 227(3):286-97.
Demichelis F
,
Setlur SR
,
Banerjee S
,
Chakravarty D
,
Chen JYun Helen
,
Chen CX
,
Huang J
,
Beltran H
,
Oldridge DA
,
Kitabayashi N
et al.
. 2012.
Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.
.
Proc Natl Acad Sci U S A. 109(17):6686-91.
Beltran H
,
Park K
,
Tagawa ST
,
Yelensky R
,
Lipson D
,
Frampton G
,
Stephens PJ
,
Cronin MT
,
Nanus DM
,
Mosquera JMiguel
et al.
. 2012.
Identifying cancer mutations in neuroendocrine prostate cancer (NEPC) through massively parallel DNA sequencing of formalin-fixed paraffin-embedded (FFPE) tissue.
.
J Clin Oncol. 30(5_suppl):110.
Collins CC
,
Volik SV
,
Lapuk AV
,
Wang Y
,
Gout PW
,
Wu C
,
Xue H
,
Cheng H
,
Haegert A
,
Bell RH
et al.
. 2012.
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.
.
Mol Cancer Ther. 11(3):775-83.
« first
‹ previous
1
2
(current)
3
next ›
last »